All In Biotech

Drug Trial Radar · NCT07503210

AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss

Efficacy and Safety of NNC0487-0111 s.c. Once Weekly in Participants With Obesity Who Have Reached Target Dose During run-in Period (AMAZE 12)

Last checked: Nov 20, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 606 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

606

Actual

Start

Apr 21, 2026

Primary completion

Jun 6, 2028

Study completion Jul 4, 2028

Sponsor

Lead sponsor
Novo Nordisk A/SNovo Nordisk (NVO)
Sponsor type
Industry
First posted
Mar 31, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have excess body weight. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111 (the treatment being tested) or Placebo (a treatment that has no active medicine in it). Which treatment participants get is decided by chance.

Conditions

  • Obesity

Interventions

  • NNC0487-0111Drug

    NNC0487-0111 will be administered subcutaneously.

  • Placebo (matched to NNC0487-0111)Drug

    Placebo will be administered subcutaneously.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Relative change in body weightTime frame: From week 40 to week 92

Locations

72 sites in 12 countries. Site status is shown where the registry gives one.

  • Pinnacle Research Group LLC

    Anniston, Alabama

  • Diablo Clinical Research, Inc.

    Walnut Creek, California

  • Florida Inst For Clin Res LLC

    Orlando, Florida

  • Endeavor Health

    Skokie, Illinois

  • Midwest Inst For Clin Res

    Indianapolis, Indiana

  • Medication Mgmnt, LLC_Grnsboro

    Greensboro, North Carolina

  • PMG Research of Wilmington LLC

    Wilmington, North Carolina

  • UPA Ctr Weight and Eating Dis

    Philadelphia, Pennsylvania

  • Clinical Res Collaborative

    Cumberland, Rhode Island

  • North Texas Endocrine Center

    Dallas, Texas

  • UT Southwestern Med Cntr

    Dallas, Texas

  • Selma Medical Associates

    Winchester, Virginia

  • Rainier Clin Res Ctr Inc

    Renton, Washington

  • CIPREC Pueyrredon

    Buenos Aires, Argentina

  • Conexa

    Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

  • CICEMO- Consultorio (Av Directorio)

    Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina

  • Instituto de Investigaciones Clinicas Mar Del Plata

    Mar del Plata, Buenos Aires, Argentina

  • Sydney Clinical Trials

    Campbelltown, New South Wales, Australia

  • Sydney Cardiometabolic Centre

    Liverpool, New South Wales, Australia

  • Hunter Diabetes Centre

    Merewether, New South Wales, Australia

  • Nightingale Research Adelaide

    Adelaide, South Australia, Australia

  • Anima Research Center

    Diepenbeek, Belgium

  • AZ Groeninge - Kortrijk - Centrum Endo - Diabetologie

    Kortrijk, Belgium

  • Centre hospitalier universitaire de Liège (CHU de Liège)

    Liège, Belgium

  • AZ OOSTENDE (Campus DAMIAAN)

    Ostend, Belgium

  • DCC 1 - Lom EOOD

    Lom, Bulgaria

  • MHAT Med Line Clinic

    Plovdiv, Bulgaria

  • UMHAT Kaspela EOOD, Endocrinology and Metabolic Diseases Clinic

    Plovdiv, Bulgaria

  • AIPSOMCEMD ENDO MED CONSULT 2020 - Dr. Aleksander Botushanov EOOD

    Plovdiv, Bulgaria

  • SGHAT Dr. Shterev EOOD

    Sofia, Bulgaria

  • UMHAT Aleksandrovska EAD, Clinic of Endocrinology and Metabolic Diseases

    Sofia, Bulgaria

  • Medical Center Maraya Med EOOD

    Sofia, Bulgaria

  • AIPSMC Dr. Traykovska EOOD

    Sofia, Bulgaria

  • Sjællands Universitetshospital, Køge - Medicinsk Afdeling

    Køge, Region Sjælland, Denmark

  • Sydvestjysk Sygehus Esbjerg - Medicinsk Endokrinologisk Ambulatorium, Forskningsenheden

    Esbjerg, Region Syddanmark, Denmark

  • Sanos Clinic - Vejle

    Vejle, Region Syddanmark, Denmark

  • CHU DE CLERMONT-FERRAND-HOPITAL GABRIEL MONTPIED_Service de Nutrition

    Clermont-Ferrand, France

  • CHU GRENOBLE ALPES-SITE NORD MICHALLON_Endocrinologie,diabétologie,maladies de la nutrition

    La Tronche, France

  • GROUPE SOS SANTE-HOPITAL LE CREUSOT-HOTEL DIEU_ Service de Diabétologie

    Le Creusot, France

  • CHU LILLE-HOPITAL CLAUDE HURIEZ_Service de Chirurgie Générale et Endocrinienne

    Lille, France

Showing 40 of 72 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.